Efficacy of Tocilizumab For Treatment of Severe COVID-19 Pneumonia: More Evidence Is Needed
Clin Infect Dis
.
2021 Jul 1;73(1):e271-e272.
doi: 10.1093/cid/ciaa1284.
Authors
Bruno De Oliveira
1
,
Jihad Mallat
1
2
Affiliations
1
Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
2
Normandy University, UNICAEN, ED 497, Caen, France.
PMID:
32886762
PMCID:
PMC7499556
DOI:
10.1093/cid/ciaa1284
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
COVID-19 Drug Treatment*
Humans
SARS-CoV-2
Substances
Antibodies, Monoclonal, Humanized
tocilizumab